Top Markets
Coin of the day
Palvella Therapeutics, Inc. Palvella Therapeutics, Inc.

Palvella Therapeutics, Inc.

PVLA
Rang în acțiuni #6138
Palvella Therapeutics, Inc. is a clinical-stage biopharmaceutical company... Palvella Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative treatments for patients afflicted with severe and uncommon inherited skin conditions. Central to its pipeline is QTORIN 3.9% rapamycin anhydrous gel (referred to as QTORIN rapamycin), which is currently undergoing Phase 3 clinical trials for microcystic lymphatic malformations. Additionally, this drug is in Phase 2 evaluation for treating cutaneous venous malformations. Beyond these specific indications, Palvella is also advancing QTORIN rapamycin for the treatment of other dermatological diseases driven by the mTOR pathway. The company's headquarters are situated in Wayne, Pennsylvania.
Preț acțiune
$154.04
Capitalizare de piață
$2.21B
Schimbare (1 zi)
-0.19%
Schimbare (1 an)
172.88%
Țară
US
Tranzacționează Palvella Therapeutics, Inc. (PVLA)

Categorie

Istoric al prețului acțiunii pentru Palvella Therapeutics, Inc. (PVLA)
Cel mai mare preț de închidere: $151.69 pe 2026-08-01

Cel mai mic preț de închidere: $13.11 pe 2024-12-01
Istoric al prețului acțiunii pentru Palvella Therapeutics, Inc. din 2024 până în 2026
Evoluția anuală a prețului acțiunii
An Performanță
2026 (TTM) 7.48%
2025 649.84%
2024 0.00%
Prețul acțiunii pentru companii similare sau concurente
Companie Preț acțiune Variație 1an% Țara
$547.65 40.75%
US
$1.06K 49.04%
NL
$122.63 -12.65%
AU
$143.63 472.23%
US
$765.25 7.19%
CH